Venous Thrombosis Deep (Limbs)
7
0
0
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
66.7%
-19.9% vs benchmark
43%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (7)
A Registry of the FLOWRUNNER Aspiration System for Patients With Symptomatic Venous Thrombosis
Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation
Pressure Ulcer Development Device Related
Design and Rationale of the COLT Study
Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
EXERT: Exercise Physiology After Thrombosis
Upper Limb Thrombosis Associated With Midline Catheter